Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20120901

High-affinity and selective dopamine D₃ receptor full agonists.

Bioorganic & medicinal chemistry letters 20120901

Spontaneous unwelcome orgasms due to pramipexole and ropinirole.

Movement disorders : official journal of the Movement Disorder Society 20120901

Therapies in Parkinson's disease.

Current opinion in neurology 20120801

The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.

Sleep 20120801

Depression in Parkinson's disease: diagnosis and treatment.

Arquivos de neuro-psiquiatria 20120801

Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.

Behavioural brain research 20120715

Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.

The International journal of neuroscience 20120701

Differentiation of enantiomeric drugs by iodo-substituted L-amino acid references under electrospray ionization mass spectrometric conditions.

Rapid communications in mass spectrometry : RCM 20120615

Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120601

Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Experimental and clinical psychopharmacology 20120601

Reversible antecollis associated with pramipexole in a patient with Parkinson's disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20120601

Midbrain tremor: a tremor resistant to treatment.

Acta neurologica Belgica 20120601

Finasteride attenuates pathological gambling in patients with Parkinson disease.

Journal of clinical psychopharmacology 20120601

Dopamine dysregulation syndrome including mania related to coadministration of droxidopa.

Journal of clinical psychopharmacology 20120601

Dissociation of periodic leg movements from arousals in restless legs syndrome.

Annals of neurology 20120601

Initiatives to improve prescribing efficiency for drugs to treat Parkinson's disease in Croatia: influence and future directions.

Expert review of pharmacoeconomics & outcomes research 20120601

Anhedonia in Japanese patients with Parkinson's disease: analysis using the Snaith-Hamilton Pleasure Scale.

Clinical neurology and neurosurgery 20120501

Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.

Sleep medicine 20120501

Dopamine agonist-induced penile erection and yawning: differential role of D₂-like receptor subtypes and correlation with nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats.

Behavioural brain research 20120501

Neural stem cell niches in health and diseases.

Current pharmaceutical design 20120501

A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.

Movement disorders : official journal of the Movement Disorder Society 20120501

Drug safety evaluation of rotigotine.

Expert opinion on drug safety 20120501

[Othello syndrome induced by pramipexole].

Revista de neurologia 20120416

Photo-degradation products of pramipexole.

Bioorganic & medicinal chemistry letters 20120415

An upper limb variant of RLS? Report of 2 cases.

Clinical neurology and neurosurgery 20120401

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120401

Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?

The journal of headache and pain 20120401

Dopamine agonists in dihydropteridine reductase deficiency.

Molecular genetics and metabolism 20120401

[Disinhibitory abnormal behavior induced by treatment of Parkinson disease].

Brain and nerve = Shinkei kenkyu no shinpo 20120401

[Fatigue and weight loss in Parkinson's disease].

Brain and nerve = Shinkei kenkyu no shinpo 20120401

Modeling mitochondrial dysfunctions in the brain: from mice to men.

Journal of inherited metabolic disease 20120301

Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.

Journal of psychiatry & neuroscience : JPN 20120301

The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120301

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.

Pharmacological research 20120301

Evaluation of periodic limb movements in a putative animal model of restless leg syndrome.

Movement disorders : official journal of the Movement Disorder Society 20120301

CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine.

Neuropharmacology 20120301

The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity.

Neurobiology of disease 20120301

Novel extraction technique to remove a penile constriction device.

The journal of sexual medicine 20120301

Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder.

The Tohoku journal of experimental medicine 20120301

Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.

European journal of pharmacology 20120227

Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats.

Brain research 20120209

Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).

Sleep medicine 20120201

Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.

Psychopharmacology 20120101

Effect of pramipexole on cutaneous-silent-period parameters in patients with restless legs syndrome.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20120101

Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.

European journal of clinical pharmacology 20120101

Outcomes from switching from rotigotine patch to alternate therapies in Parkinson's disease.

The International journal of neuroscience 20120101

Dopamine agonist use and the risk of heart failure.

Pharmacoepidemiology and drug safety 20120101

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.

Sleep medicine 20120101

Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

The Journal of clinical psychiatry 20120101

Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.

Clinical schizophrenia & related psychoses 20120101

Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease.

Parkinson's disease 20120101

Impact of anxiety on quality of life in Parkinson's disease.

Parkinson's disease 20120101

The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.

PloS one 20120101

The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Parkinson's disease 20120101

A combination of dopamine genes predicts success by professional Wall Street traders.

PloS one 20120101

Risk of falls in Parkinson's disease: a cross-sectional study of 160 patients.

Parkinson's disease 20120101

Patient considerations in early management of Parkinson's disease: focus on extended-release pramipexole.

Patient preference and adherence 20120101

Pramipexole may be an effective treatment option in essential tremor.

Clinical neuropharmacology 20120101

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

BMJ open 20120101

Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease.

ISRN neurology 20120101

Restless leg syndrome, periodic limb movements, febrile seizures and Attention deficit hyperactivity disorder in an Indian family.

Annals of Indian Academy of Neurology 20120101

Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: A before-after study.

Neuro endocrinology letters 20120101

The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial.

Evidence-based complementary and alternative medicine : eCAM 20120101

Successful treatment with clonazepam and pramipexole of a patient with sleep-related eating disorder associated with restless legs syndrome: a case report.

Case reports in medicine 20120101

Dyskinesias and treatment with pramipexole in patients with Parkinson's disease.

Parkinson's disease 20120101

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease.

Clinical interventions in aging 20120101

Nightmare-enacting behavior responding to zonisamide in early Parkinson's disease.

Case reports in neurology 20120101

A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism.

PloS one 20120101

Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum.

Annals of Indian Academy of Neurology 20120101

Dopamine agonists and pathologic behaviors.

Parkinson's disease 20120101

Role of gabapentin enacarbil XR in restless legs syndrome.

Therapeutics and clinical risk management 20120101

Huntington's disease.

Handbook of clinical neurology 20120101

Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.

International journal of nanomedicine 20120101

Treatment-resistant Schizophrenia: Evidence-based Strategies.

Mens sana monographs 20120101

Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects.

Frontiers in psychiatry 20120101

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Frontiers in neurology 20120101

Reviewing two types of addiction - pathological gambling and substance use.

Indian journal of psychological medicine 20120101

Parallel appearance of compulsive behaviors and artistic creativity in Parkinson's disease.

Case reports in neurology 20120101

Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.

Depression research and treatment 20120101

Clinical aspects and management of levodopa-induced dyskinesia.

Parkinson's disease 20120101

A tribute to charlie chaplin: induced positive affect improves reward-based decision-learning in Parkinson's disease.

Frontiers in psychology 20120101

Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial.

Clinical neuropharmacology 20120101

The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial.

TheScientificWorldJournal 20120101

The effect of pramipexole therapy on balance disorder and fall risk in Parkinson's disease at early stage: clinical and posturographic assessment.

ISRN neurology 20120101

Pramipexole upregulates dopamine receptor D₂ and D₃ expression in rat striatum.

Journal of pharmacological sciences 20120101

An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research.

Journal of gambling studies 20111201

Temporal stability of the Unified Dyskinesia Rating Scale.

Movement disorders : official journal of the Movement Disorder Society 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease.

Hiroshima journal of medical sciences 20111201

Dopamine D2-like receptor agonists induce penile erection in male rats: differential role of D2, D3 and D4 receptors in the paraventricular nucleus of the hypothalamus.

Behavioural brain research 20111120

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.

Nature medicine 20111120

Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease.

European journal of neurology 20111101

Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

Brain structure & function 20111101

Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database.

European journal of clinical pharmacology 20111101

Development and validation of a chiral capillary electrophoresis method for assay and enantiomeric purity control of pramipexole.

Journal of separation science 20111101

Restless legs syndrome in subjects with a knee prosthesis: evidence that symptoms are generated in the periphery.

Clinics (Sao Paulo, Brazil) 20111101

Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.

Biological psychiatry 20111015

Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.

Pharmacology, biochemistry, and behavior 20111001

Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.

Pharmacology, biochemistry, and behavior 20111001

Pharmacokinetic evaluation of pramipexole.

Expert opinion on drug metabolism & toxicology 20111001

Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.

Behavioural pharmacology 20111001

Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.

Prescrire international 20111001

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20111001

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20111001

Electrode position and the clinical outcome after bilateral subthalamic nucleus stimulation.

Journal of Korean medical science 20111001

Restless abdomen: a phenotypic variant of restless legs syndrome.

Neurology 20110927

Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.

European journal of pharmacology 20110901

Acupuncture for restless legs syndrome in patients previously treated with dopaminergic drugs.

Acupuncture in medicine : journal of the British Medical Acupuncture Society 20110901

Pramipexole extended release in Parkinson's disease.

Expert review of neurotherapeutics 20110901

Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD.

Brain and behavior 20110901

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial.

Neurology 20110823

Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial.

Neurology 20110823

Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.

Neuroscience letters 20110815

Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects.

Journal of clinical pharmacology 20110801

Pathological gambling plus hypersexuality in restless legs syndrome: a new case.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110801

Migraine and restless legs syndrome: is there an association?

The journal of headache and pain 20110801

Effects of selective dopaminergic compounds on a delay-discounting task.

Behavioural pharmacology 20110801

Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease.

CNS drugs 20110801

Disease modification in Parkinson's disease.

Drugs & aging 20110801

Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.

Physiology & behavior 20110725

Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.

Neurology 20110712

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110701

Anhedonia in Japanese patients with Parkinson's disease.

Geriatrics & gerontology international 20110701

Reward processing abnormalities in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20110701

Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials.

Movement disorders : official journal of the Movement Disorder Society 20110701

Pramipexole for the treatment of early Parkinson's disease.

Expert review of neurotherapeutics 20110701

Treatment in late Parkinson's disease.

Annals of Indian Academy of Neurology 20110701

Motor fluctuations and dyskinesias (diagnosis and management).

Annals of Indian Academy of Neurology 20110701

Psychosis in Parkinson's disease.

Annals of Indian Academy of Neurology 20110701

Initiation of treatment in early PD (evidences based).

Annals of Indian Academy of Neurology 20110701

Treatment-resistant sensory motor symptoms in persons with SCI may be signs of restless legs syndrome.

Spinal cord 20110601

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Psychopharmacology 20110601

Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Sleep medicine 20110601

Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats.

The European journal of neuroscience 20110601

Therapies for dopaminergic-induced dyskinesias in Parkinson disease.

Annals of neurology 20110601

Medical management of Parkinson's disease: focus on neuroprotection.

Current neuropharmacology 20110601

Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression.

The international journal of neuropsychopharmacology 20110501

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Sleep medicine 20110501

Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype.

Neuropharmacology 20110501

Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.

Parkinsonism & related disorders 20110501

Utilization of anti-Parkinson drugs in Australia: 1995-2009.

Pharmacoepidemiology and drug safety 20110501

Pramipexole modulates the neural network of reward anticipation.

Human brain mapping 20110501

Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.

Sleep medicine 20110501

Milestones in Parkinson's disease therapeutics.

Movement disorders : official journal of the Movement Disorder Society 20110501

Development and validation of GC/MS method for determination of pramipexole in rat plasma.

Biomedical chromatography : BMC 20110401

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.

Psychopharmacology 20110401

The first case of a 'jumping stump' syndrome in a lower limb amputee responding to pramipexole.

European journal of neurology 20110401

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.

Sleep medicine 20110401

Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia.

Journal of clinical psychopharmacology 20110401

Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome.

Movement disorders : official journal of the Movement Disorder Society 20110401

Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study.

The Laryngoscope 20110401

[Adverse effect of Sifrol or not?].

Lakartidningen 20110401

Dopamine agonists for restless legs syndrome.

The Cochrane database of systematic reviews 20110316

Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.

The Journal of clinical psychiatry 20110301

Sleep disorders in patients with traumatic brain injury: a review.

CNS drugs 20110301

Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.

European journal of neurology 20110301

Treatment of depressive symptoms in Parkinson's disease.

European journal of neurology 20110301

Hemiparkinsonism-hemiatrophy syndrome.

Archives of Iranian medicine 20110301

Depressogenic effects of medications: a review.

Dialogues in clinical neuroscience 20110301

Levodopa for restless legs syndrome.

The Cochrane database of systematic reviews 20110216

The effect of pramipexole on depressive symptoms in Parkinson's disease.

The Kobe journal of medical sciences 20110202

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.

Neurogenetics 20110201

Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials.

Sleep medicine 20110201

Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: An economic Markov model evaluation.

Drugs & aging 20110201

Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats.

Psychopharmacology 20110101

Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.

Sleep medicine 20110101

Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.

Movement disorders : official journal of the Movement Disorder Society 20110101

Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.

Sleep medicine 20110101

Serotonin and dopamine play complementary roles in gambling to recover losses.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110101

Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.

Neuropharmacology 20110101

The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.

Sleep medicine 20110101

Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.

Neuropsychobiology 20110101

A meta-analysis of pain response in the treatment of fibromyalgia.

Pain practice : the official journal of World Institute of Pain 20110101

[Possibilities and limitations of psychopharmacological treatments in patients with psychological comorbidity].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20110101

Pathological gambling in a bipolar patient treated with pramipexole.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).

Movement disorders : official journal of the Movement Disorder Society 20110101

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care.

BMC neurology 20110101

Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients.

PloS one 20110101

New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges.

Parkinson's disease 20110101

Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients.

Neuro endocrinology letters 20110101

Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.

PloS one 20110101

Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Parkinson's disease 20110101

FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.

BMC neurology 20110101

Predicting drug side-effect profiles: a chemical fragment-based approach.

BMC bioinformatics 20110101

Dopamine-induced nonmotor symptoms of Parkinson's disease.

Parkinson's disease 20110101

Available and emerging treatments for Parkinson's disease: a review.

Drug design, development and therapy 20110101

Noradrenaline and Parkinson's disease.

Frontiers in systems neuroscience 20110101

Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome.

Neuropsychiatric disease and treatment 20110101

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson's disease: implications for patients.

Neuropsychiatric disease and treatment 20110101

Sleep Duration and 'on' Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release.

Parkinson's disease 20110101

Visual symptoms in Parkinson's disease.

Parkinson's disease 20110101

Neurobiology of depression and anxiety in Parkinson's disease.

Parkinson's disease 20110101

Agonist-specific voltage sensitivity at the dopamine D2S receptor--molecular determinants and relevance to therapeutic ligands.

Neuropharmacology 20110101

Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

PloS one 20110101

Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.

Frontiers in systems neuroscience 20110101

Pharmacotherapy for fibromyalgia.

Frontiers in pharmacology 20110101

Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.

BMC neurology 20110101

Case control polysomnographic studies of sleep disorders in Parkinson's disease.

PloS one 20110101

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease.

BMC neurology 20110101

Sleep disturbances associated with Parkinson's disease.

Parkinson's disease 20110101

Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.

Frontiers in neuroanatomy 20110101

Modulation of human time processing by subthalamic deep brain stimulation.

PloS one 20110101

Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.

BMC neurology 20110101

Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Panic attack-like episodes possibly induced by pramipexole in a patient with young-onset Parkinson's disease.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.

BMC neurology 20110101

Pramipexole reduces the prevalence of fatigue in patients with Parkinson's disease.

Internal medicine (Tokyo, Japan) 20110101

Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease.

Pharmacological reports : PR 20110101

Management of bipolar depression.

Indian journal of psychological medicine 20110101

Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.

Swiss medical weekly 20110101

nardosinane-type sesquiterpenoids from the formosan soft coral Paralemnalia thyrsoides.

Marine drugs 20110101

Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Neurology research international 20110101

Sentence comprehension and its association with executive functions in patients with Parkinson's disease.

Parkinson's disease 20110101

Bipolar affective disorder and Parkinson's disease.

Case reports in medicine 20110101

Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging.

Frontiers in neurology 20110101

Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).

Journal of drug delivery 20110101

Pregnancy in multiple system atrophy: a case report.

Journal of medical case reports 20110101

Pramipexole-induced peripheral edema in a patient with bipolar depression.

The Journal of neuropsychiatry and clinical neurosciences 20110101

A role for locus coeruleus in Parkinson tremor.

Frontiers in human neuroscience 20110101

Proton magnetic resonance spectroscopy in depression.

Indian journal of psychiatry 20110101

Periodic Limbic Movement Disorder during Sleep as Diabetes-Related Syndrome? A Polysomnographic Study.

ISRN endocrinology 20110101

Apathy and anhedonia in Parkinson's disease.

ISRN neurology 20110101

Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.

Movement disorders : official journal of the Movement Disorder Society 20101215

Stability studies and structural characterization of pramipexole.

Journal of pharmaceutical and biomedical analysis 20101201

Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release.

European journal of nuclear medicine and molecular imaging 20101201

Pramipexole for stage 2 treatment-resistant major depression: an open study.

Progress in neuro-psychopharmacology & biological psychiatry 20101201

Dopamine agonists and Othello's syndrome.

Parkinsonism & related disorders 20101201

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal 20101201

Seniors with Parkinson's disease: initial medical treatment.

Journal of clinical neurology (Seoul, Korea) 20101201

Successful drug development despite adverse preclinical findings part 2: examples.

Journal of toxicologic pathology 20101201

Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.

The Lancet. Neurology 20101126

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20101115

From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease.

Pharmacology & therapeutics 20101101

Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

CNS drugs 20101101

Validated ultra-performance liquid chromatography tandem mass spectrometry method for the determination of pramipexole in human plasma.

Journal of chromatographic science 20101101

The role of pramipexole in a severe Parkinson's disease model in mice.

Therapeutic advances in neurological disorders 20101101

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20101030

Toxicity assessment of pramipexole in juvenile rhesus monkeys.

Toxicology 20101029

Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease.

Neurochemical research 20101001

Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.

Psychopharmacology 20101001

Role of pramipexole in the management of Parkinson's disease.

CNS drugs 20101001

Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101001

Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.

Neurocase 20101001

[Dopaminergic neuroprotection and reconstruction of neural network tiara].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101001

Clozapine for medication-related pathological gambling in Parkinson disease.

Movement disorders : official journal of the Movement Disorder Society 20100915

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database.

Movement disorders : official journal of the Movement Disorder Society 20100915

Long-term use of pramipexole in bipolar depression: a naturalistic retrospective chart review.

The Psychiatric quarterly 20100901

Isolated delusional syndrome in Parkinson's Disease.

Parkinsonism & related disorders 20100901

An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.

The Annals of pharmacotherapy 20100901

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.

Expert opinion on pharmacotherapy 20100901

Recurrence of cluster headache with pramipexole.

Acta neurologica Belgica 20100901

Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study.

Movement disorders : official journal of the Movement Disorder Society 20100815

Uptake of pramipexole by human organic cation transporters.

Molecular pharmaceutics 20100802

Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence.

The American journal of geriatric pharmacotherapy 20100801

Drug safety monitoring in patients of movement disorders of a tertiary care hospital.

Indian journal of pharmacology 20100801

Long-term open-label study of pramipexole in patients with primary restless legs syndrome.

Journal of the neurological sciences 20100715

Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats.

Synapse (New York, N.Y.) 20100701

Trials of neuroprotective therapies for Parkinson's disease: problems and limitations.

Parkinsonism & related disorders 20100701

Transdermal rotigotine for the perioperative management of Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) 20100701

Bipolar disorder: an update.

Postgraduate medicine 20100701

Coexisting huntingtin and SCA8 repeat expansion: case report of a severe complex neurodegenerative syndrome.

Journal of the neurological sciences 20100615

Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.

Experimental neurology 20100601

Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.

Pharmacology, biochemistry, and behavior 20100601

Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

CNS neuroscience & therapeutics 20100601

Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

The Lancet. Neurology 20100601

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

The Lancet. Neurology 20100601

Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?

The Lancet. Neurology 20100601

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Archives of general psychiatry 20100601

Effects of pramipexole on impulsive choice in male wistar rats.

Experimental and clinical psychopharmacology 20100601

Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability.

Sleep 20100601

Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

Experimental neurobiology 20100601

[Clinical studies on pramipexol retard].

Ideggyogyaszati szemle 20100530

Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants.

Journal of psychopharmacology (Oxford, England) 20100501

[Management of restless legs syndrome].

Presse medicale (Paris, France : 1983) 20100501

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Archives of neurology 20100501

Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.

Progress in neuro-psychopharmacology & biological psychiatry 20100416

Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.

Pharmacy world & science : PWS 20100401

Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100401

Pramipexole extended release: in Parkinson's disease.

CNS drugs 20100401

[Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].

Revista medica de Chile 20100401

Compulsive habits in restless legs syndrome patients under dopaminergic treatment.

Journal of the neurological sciences 20100315

Patent watch.

Nature reviews. Drug discovery 20100301

[Clinical data of the prolonged-release formulation of ropinirole].

Fortschritte der Neurologie-Psychiatrie 20100301

The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Behavioural pharmacology 20100301

Use of the D2/D3 receptor agonist pramipexole in treatment of rapid-cycling bipolar disorder in an elderly patient.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20100301

Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.

The American journal of managed care 20100301

Othello syndrome in patients with Parkinson's disease.

Psychiatria Danubina 20100301

Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.

Movement disorders : official journal of the Movement Disorder Society 20100215

Best practice guide for the treatment of REM sleep behavior disorder (RBD).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100215

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study.

Journal of neurology 20100201

Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance.

Current opinion in pharmacology 20100201

Successful treatment of restless legs syndrome with the herbal prescription Yokukansan.

Progress in neuro-psychopharmacology & biological psychiatry 20100201

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.

Psychopharmacology 20100201

Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Pharmaceutical research 20100201

Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials.

Drug safety 20100201

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

Clinical therapeutics 20100201

Decision-making during gambling: an integration of cognitive and psychobiological approaches.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20100127

Zolpidem-induced sleep-related eating disorder.

Journal of the neurological sciences 20100115

Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.

Sleep medicine 20100101

Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Psychopharmacology 20100101

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.

Clinical neuropharmacology 20100101

Impulse control disorder and piribedil: report of 5 cases.

Clinical neuropharmacology 20100101

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Sleep medicine 20100101

Why do some promising brain-stimulation devices fail the next steps of clinical development?

Expert review of medical devices 20100101

Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease.

Archives of neurology 20100101

Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.

Sleep 20100101

Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole.

BMC pharmacology 20100101

Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

The Journal of neuropsychiatry and clinical neurosciences 20100101

[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

Delusion of Cotard's syndrome successfully treated with a dopamine agonist.

The Journal of neuropsychiatry and clinical neurosciences 20100101

Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.

Psychosomatics 20100101

Gabapentin enacarbil - clinical efficacy in restless legs syndrome.

Neuropsychiatric disease and treatment 20100101

[Effects of the dopamine agonist mirapex (pramipexole) therapy on sleep disorders in Parkinson's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

BMC neurology 20100101

Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Neuropsychiatric disease and treatment 20100101

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's disease.

Core evidence 20100101

Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report.

Journal of medical case reports 20100101

Remission of severe restless legs syndrome and periodic limb movements in sleep after bilateral excision of multiple foot neuromas: a case report.

Journal of medical case reports 20100101

Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Clinical interventions in aging 20100101

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).

Neuropsychiatric disease and treatment 20100101

Circadian rhythm disturbances in patients with Alzheimer's disease: a review.

International journal of Alzheimer's disease 20100101

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch.

BMC neurology 20100101

Validation of a column liquid chromatographic method for the analysis of pramipexole and its five impurities.

Journal of AOAC International 20100101

The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates.

Parkinson's disease 20100101

Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness.

Clinical neuropharmacology 20100101

Extrastriatal dopaminergic circuits of the Basal Ganglia.

Frontiers in neuroanatomy 20100101

Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys.

PloS one 20100101

Pramipexole extended release: a novel treatment option in Parkinson's disease.

Parkinson's disease 20100101

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction.

Journal of human reproductive sciences 20100101

Synthesis, Characterization, and Biological Evaluation of certain 6-methyl-2(3H)-benzo-1, 3-thiazolyl-1'-ethylidene-2-(o, p- Substituted Acetophenones) Hydrazine Analogs.

Journal of young pharmacists : JYP 20100101

Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability.

ClinicoEconomics and outcomes research : CEOR 20100101

Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine.

BMJ case reports 20100101

Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.

Journal of the neurological sciences 20091215

Dopamine agonist-induced antecollis in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20091215

Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society 20091215

Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.

Clinical and experimental pharmacology & physiology 20091201

Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.

Neurochemistry international 20091201

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.

European journal of clinical pharmacology 20091201

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20091201

Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole.

Current medical research and opinion 20091201

Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.

Pharmacotherapy 20091201

Dopamine receptor agonists and sleep disturbances in Parkinson's disease.